Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
zhangyanming
- Development stage
- Unknown
- Lead developer
- Shen Neng Herbal Medicines
- Modality
- Implantable Devices → Device-based Delivery → Drug Delivery Systems, Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Inhalation Devices → Device-based Delivery → Drug Delivery Systems
- Administration
- Oral
01
Overview
Zhangyanming (also known as Zhang Yan Ming Pian or ZYMT) is a proprietary traditional Chinese medicine formulation used primarily for the treatment of cataracts and related eye conditions. It is indicated for symptoms such as dry eyes, uniocular diplopia (double vision in one eye), soreness and weakness of the waist and knees, slight hypopsia (reduced vision), and is especially recommended for initial or middle stages of senile cataract. The formula is said to benefit the liver, nourish the kidneys, clear heat, and brighten the eyes according to traditional Chinese medicine principles. It contains a variety of herbal ingredients commonly used in TCM[1][2][3][4].
- Brand names
- Zhang Yan MingZhang Yan Ming PianZHANG YAN MING TABLETS
- Other names
- ZYMTZhangyanming Tablets
Beyond the preview
Go deeper on zhangyanming.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on zhangyanming.